New aspects in the treatment of AIDS-related lymphoma.
Despite of changes in the use of antiviral or chemotherapy regimens, the median survival of patients with AIDS-related lymphoma has not significantly changed until recently. However, partly due to prolonged survival with the introduction of highly active antiretroviral therapy (HAART) prognosis in AIDS patients with lymphoma seems to improve. Recently, several new treatment options have been explored in patients with lymphoma. It is hoped that novel strategies will lead to a survival benefit in these patients. In this review, we discuss the current strategies for the treatment of AIDS-related lymphoma.
Schmidt-Wolf
I G H
IG
Medizinische Universitätsklinik und Poliklinik I, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany. picasso@uni-bonn.de
Rockstroh
J K
JK
Schlegel
U
U
Pels
H
H
Weiss
R
R
Huhn
D
D
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006689:Hodgkin Disease / Q000150:complications / Q000628:therapy; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007167:Immunotherapy / Q000379:methods; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D033581:Stem Cell Transplantation
D000970:Antineoplastic Agents; D006918:Hydroxyurea